Catalyst Funds Management’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
NPCM
Catalyst Funds Management's AGL Position: Q1 2026 in Review
Catalyst Funds Management sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 576 shares — an estimated $9.92K sold.
Catalyst Funds Management first reported a position in AGL in Q2 2025 and held it in 2 quarters. The position peaked at $24.4K in Q2 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.
- Catalyst Funds Management reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
- Catalyst Funds Management sold 576 Agilon Health shares in Q1 2026, an estimated $9.92K.
- Catalyst Funds Management first reported a position in Agilon Health in Q2 2025 and held it in 2 quarters.
- Catalyst Funds Management's Agilon Health position peaked at $24.4K in Q2 2025.
- 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.
Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.